Home > > > > > Report Detail

Asia Cervical Cancer Diagnostic Market, By Test Type (Pap smear, HPV DNA and VIA), Countries & Forecast

Publisher Name :
Date: 14-Jun-2018
No. of pages: 155
Inquire Before Buying

Cervical cancer is the fourth most common cancer prevailing in women and the seventh in terms of overall cancer incidences. Cervical cancer test market in Asian region is growing and expected to cross over 1,000 million dollars by 2024. Cervical cancer affects the lower part of the uterus (womb). Cervical cancer generally occurs in women over 30 years. It is mostly caused by the Human papillomavirus (HPV) virus. Despite declining women population, Japan has highest market share in cervical cancer test market. Whereas Indonesia is dominating in cervical cancer testing population followed by China.

Growing women population, rising sum of structured cervical cancer programs introduced by governments and international NGOs and inception of low cost VIA test are some of the major growth drivers for the growth of cervical cancer test market in the developing countries.  

Renub Research report titled “Asia Cervical Cancer Diagnostic Market, By Test Type (Pap smear, HPV DNA and VIA), Countries (Japan, Korea, Singapore, Malaysia, India, China, Thailand and Indonesia) & Forecast” provides a complete analysis of Asia Cervical Cancer Screening Market. The report provides a complete analysis of Asia Countries Cervical Cancer Test Market, Screened Population & Mortality.

By Test Types – Pap smear Screening Tests is gaining popularity in Asia, although VIA has bright future due to its lower cost characteristic.

The report studies the market and population of the following cervical cancer screening tests: Pap smear Tests, HPV DNA Tests and VIA Tests. Pap smears and VIA tests is more popular with the developing countries such as India, China, and Indonesia.

By Country – Indonesia and China holds the largest share by Population

The report studies the market/screened population of Eight big Asian countries (Japan, Korea, Singapore, Malaysia, India, China, Thailand and Indonesia) which provides a complete country-wise analysis of Asia Cervical Cancer Screening Market.

All the 8 Asian countries in the report have been studied from 3 viewpoints.

Cervical Cancer Diagnostic Market


  • Pap Smear Tests Market

  • HPV DNA Tests Market

  • VIA Tests Market


Cervical Cancer Test Population


  • Pap Smear Test Population

  • HPV DNA Test Population

  • VIA Test Population


Cervical Cancer Mortality Population


  • Japan

  • Korea


All the 8 Countries Studied in the Report are as Follows


  • Japan

  • Korea

  • Singapore

  • Malaysia

  • India

  • China

  • Thailand

  • Indonesia

Asia Cervical Cancer Diagnostic Market, By Test Type (Pap smear, HPV DNA and VIA), Countries & Forecast

Table of Contents

1. Executive Summary

2. Asia Cervical Cancer Test (Screening) Analysis
2.1 Asia Cervical Cancer Test Population
2.1.1 Pap smear Test Population
2.1.2 HPV DNA Test Population
2.1.3 VIA Test Population
2.2 Asia Cervical Cancer Test (Screening) Market
2.2.1 Pap Smear Test Market
2.2.2 HPV DNA Test Market
2.2.3 Visual Inspection with Acetic Acid (VIA) Test Market

3. Market & Population Share – By Countries
3.1 Asia Cervical Cancer Test Population
3.1.1 Pap Smear Population
3.1.2 HPV DNA Population
3.1.3 VIA Population
3.2 As Market Share – By Countries
3.2.1 Pap Smear Market
3.2.2 HPV DNA Market
3.2.3 VIA Market

4. Japan – Cervical Cancer Test Analysis
4.1 Population - Cervical Cancer Test (Screening)
4.1.1 Pap smear Test Population
4.1.2 HPV DNA Test Population
4.2 Japan Cervical Cancer Mortality
4.3 Market – Cervical Cancer Test (Screening)
4.3.1 Pap Smear Test Market
4.3.2 HPV DNA Test Market

5. South Korea – Cervical Cancer Tests Analysis
5.1 Population – Cervical Cancer Test (Screening)
5.1.1 Pap Smear Test Population
5.1.2 HPV DNA Test Population
5.2 Korea Cervical Cancer Mortality
5.3 Market – Cervical Cancer Test (Screening)
5.3.1 Pap Smear Test Market
5.3.2 HPV DNA Test Market

6. Singapore – Cervical Cancer Tests Analysis
6.1 Population – Cervical Cancer Test (Screening)
6.1.1 Pap Smear Test Population
6.1.2 HPV DNA Test Population
6.2 Market – Cervical Cancer Test (Screening)
6.2.1 Pap Smear Test Market
6.2.2 HPV DNA Test Market

7. Malaysia – Cervical Cancer Test Analysis
7.1 Population – Cervical Cancer Test (Screening)
7.1.1 Pap Smear Test Population
7.1.2 HPV DNA Test Population
7.2 Market – Cervical Cancer Test (Screening)
7.2.1 Pap Smear Test Market
7.2.2 HPV DNA Test Market

8. India – Cervical Cancer Test Analysis
8.1 Population – Cervical Cancer Test (Screening)
8.1.1 Pap Smear Test Population
8.1.2 HPV DNA Test Population
8.1.3 VIA Test Population
8.2 Market – Cervical Cancer Test (Screening)
8.2.1 Pap Smear Test Market
8.2.2 HPV DNA Test Market
8.2.3 VIA Test Market

9. China – Cervical Cancer Test Analysis
9.1 Population – Cervical Cancer Test (Screening)
9.1.1 Pap Smear Test Population
9.1.2 HPV DNA Test Population
9.1.3 VIA Test Population
9.2 Market – Cervical Cancer Test (Screening)
9.2.1 Pap Smear Test Population
9.2.2 HPV DNA Test Population
9.2.3 VIA Test Market

10. Thailand – Cervical Cancer Test Analysis
10.1 Population – Cervical Cancer Test (Screening)
10.1.1 Pap Smear Test Population
10.1.2 VIA Test Population
10.2 Market – Cervical Cancer Test (Screening)
10.2.1 Pap Smear Test Market
10.2.2 VIA Test Market

11. Indonesia – Cervical Cancer Test Analysis
11.1 Population – Cervical Cancer Test (Screening)
11.1.1 Pap Smear Test Population
11.1.2 HPV DNA Test Population
11.1.3 VIA Test Population
11.1.4 Pap smear & VIA Test Population
11.2 Market – Cervical Cancer Test (Screening)
11.2.1 Pap smear Test Market
11.2.2 HPV DNA Test Market
11.2.3 VIA Test Market
11.2.4 Pap smear & VIA Test Market

12. Growth Drivers
12.1 Introduction of Low Cost VIA Test
12.1.1 Countries Offering VIA Test via National Programs
12.1.2 Countries Offering VIA Test via Pilot Programs
12.2 Worldwide Rising Incidence of Teenage Sexual Cases
12.3 Worldwide High Prevalence of HPV Infected Patients

13. Challenges
13.1 Lack of Appropriate Healthcare Infrastructure
13.2 Introduction of HPV Vaccination Programs Worldwide

List of Tables:

Table 12‑1: Worldwide – List of Countries which offer VIA Test via National Programs, 2015
Table 12‑2: Worldwide – List of Countries which offer VIA Test via Pilot Programs, 2015
Table 12‑3: Worldwide – Prevalence (Percent) of Young Women (15–44 Years) who Have Sex before the Age of 15 Years, 1994 – 2006
Table 12‑4: Worldwide – Prevalence of HPV 16/18 in Women with Normal Cervical Cytology (Percent), 2014 - 2015

List of Figures:

Figure 2‑1: Asia – Cervical Cancer Test Population (Million), 2011 – 2017
Figure 2‑2: Asia – Forecast for Cervical Cancer Test Population (Million), 2018 – 2024
Figure 2‑3: Asia – Cervical Cancer Pap smear Test Population (Million), 2011 – 2017
Figure 2‑4: Asia – Forecast for Cervical Cancer Pap smear Test Population (Million), 2018 – 2024
Figure 2‑5: Asia – Cervical Cancer HPV DNA Test Population (Million), 2011 – 2017
Figure 2‑6: Asia – Forecast for Cervical Cancer HPV DNA Test Population (Million), 2018 – 2024
Figure 2‑7: Asia – Cervical Cancer VIA Test Population (Million), 2011 – 2017
Figure 2‑8: Asia – Forecast for Cervical Cancer VIA Test Population (Million), 2018 – 2024
Figure 2‑9: Asia – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 2‑10: Asia – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 2‑11: Asia – Cervical Cancer Pap smear Test Market (Million US$), 2011 – 2017
Figure 2‑12: Asia – Forecast for Cervical Cancer Pap smear Test Market (Million US$), 2018 – 2024
Figure 2‑13: Asia – Cervical Cancer HPV DNA Test Market (Million US$), 2011 – 2017
Figure 2‑14: Asia – Forecast for Cervical Cancer HPV DNA Test Market (Million US$), 2018 – 2024
Figure 2‑15: Asia – Cervical Cancer VIA Test Market (Million US$), 2011 – 2017
Figure 2‑16: Asia – Forecast for Cervical Cancer VIA Test Market (Million US$), 2018 – 2024
Figure 3‑1: Asia – Cervical Cancer Test Population Share (%), 2011 – 2017
Figure 3‑2: Asia – Forecast for Cervical Cancer Test Population Share (%), 2018 – 2024
Figure 3‑3: Asia – Cervical Cancer Pap smear Test Population Share (%), 2011 – 2017
Figure 3‑4: Asia – Forecast for Cervical Cancer Pap smear Test Population Share (%), 2018 – 2024
Figure 3‑5: Asia – Cervical Cancer HPV DNA Test Population Share (%), 2011 – 2017
Figure 3‑6: Asia – Forecast for Cervical Cancer HPV DNA Test Population Share (%), 2018 – 2024
Figure 3‑7: Asia – Cervical Cancer VIA Test Population Share (%), 2011 – 2017
Figure 3‑8: Asia – Forecast for Cervical Cancer VIA Test Population Share (%), 2018 – 2024
Figure 3‑9: Asia – Cervical Cancer Test Market Share (%), 2011 – 2017
Figure 3‑10: Asia – Forecast for Cervical Cancer Test Market Share (%), 2018 – 2024
Figure 3‑11: Asia – Cervical Cancer Pap smear Test Market Share (%), 2011 – 2017
Figure 3‑12: Asia – Forecast for Cervical Cancer Pap smear Test Market Share (%), 2018 – 2024
Figure 3‑13: Asia – Cervical Cancer HPV DNA Test Market Share (%), 2011 – 2017
Figure 3‑14: Asia – Forecast for Cervical Cancer HPV DNA Test Market Share (%), 2018 – 2024
Figure 3‑15: Asia – cervical cancer VIA Test Market Share (%), 2011 – 2017
Figure 3‑16: Asia – Forecast for cervical cancer VIA Test Market Share (%), 2018 – 2024
Figure 4‑1: Japan – Cervical Cancer Test Population (Thousand), 2011 – 2017
Figure 4‑2: Japan – Forecast for Cervical Cancer Test Population (Thousand), 2018 – 2024
Figure 4‑3: Japan – Cervical Cancer Pap Smear Test Population (Thousand), 2011 – 2017
Figure 4‑4: Japan – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 – 2024
Figure 4‑5: Japan – Cervical Cancer HPV DNA Test Population (Thousand), 2011 – 2017
Figure 4‑6: Japan – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 – 2024
Figure 4‑7: Japan – Cervical Cancer Mortality (Number), 2011 – 2017
Figure 4‑8: Japan – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 4‑9: Japan – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 4‑10: Japan – Pap Smear Test Market (Million US$), 2011 – 2017
Figure 4‑11: Japan – Forecast for Pap Smear Test Market (Million US$), 2018 – 2024
Figure 4‑12: Japan – HPV DNA Test Market (Million US$), 2011 – 2017
Figure 4‑13: Japan – Forecast for HPV DNA Test Market (Million US$), 2018 – 2024
Figure 5‑1: Korea – Cervical Cancer Test Population (Thousand), 2011 – 2017
Figure 5‑2: Korea – Forecast for Cervical Cancer Test Population (Thousand), 2018 – 2024
Figure 5‑3: Korea – Cervical Cancer Pap Smear Test Population (Thousand), 2011 – 2017
Figure 5‑4: Korea – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 – 2024
Figure 5‑5: Korea – Cervical Cancer HPV DNA Test Population (Thousand), 2011 – 2017
Figure 5‑6: Korea – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 – 2024
Figure 5‑7: Korea – Cervical Cancer Mortality (Number), 2011 – 2017
Figure 5‑8: Korea – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 5‑9: Korea – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 5‑10: Korea – Pap Smear Test Market (Million US$), 2011 – 2017
Figure 5‑11: Korea – Forecast for Pap Smear Test Market (Million US$), 2018 – 2024
Figure 5‑12: Korea – HPV DNA Test Market (Million US$), 2011 – 2017
Figure 5‑13: Korea – Forecast for HPV DNA Test Market (Million US$), 2018 – 2024
Figure 6‑1: Singapore – Cervical Cancer Test Population (Thousand), 2011 – 2017
Figure 6‑2: Singapore – Forecast for Cervical Cancer Test Population (Thousand), 2018 – 2024
Figure 6‑3: Singapore – Cervical Cancer Pap Smear Test Population (Thousand), 2011 – 2017
Figure 6‑4: Singapore – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 – 2024
Figure 6‑5: Singapore – Cervical Cancer HPV DNA Test Population (Thousand), 2011 – 2017
Figure 6‑6: Singapore – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 – 2024
Figure 6‑7: Singapore – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 6‑8: Singapore – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 6‑9: Singapore – Pap Smear Test Market (Million US$), 2011 – 2017
Figure 6‑10: Singapore – Forecast for Pap Smear Test Market (Million US$), 2018 – 2024
Figure 6‑11: Singapore – HPV DNA Test Market (Million US$), 2011 – 2017
Figure 6‑12: Singapore – Forecast for HPV DNA Test Market (Million US$), 2018 – 2024
Figure 7‑1: Malaysia – Cervical Cancer Test Population (Thousand), 2011 – 2017
Figure 7‑2: Malaysia – Forecast for Cervical Cancer Test Population (Thousand), 2018 – 2024
Figure 7‑3: Malaysia – Cervical Cancer Pap Smear Test Population (Thousand), 2011 – 2017
Figure 7‑4: Malaysia – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 – 2024
Figure 7‑5: Malaysia – Cervical Cancer HPV DNA Test Population (Thousand), 2011 – 2017
Figure 7‑6: Malaysia – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 – 2024
Figure 7‑7: Malaysia – Cervical Cancer Test Market (Million US$), 2011– 2017
Figure 7‑8: Malaysia – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 7‑9: Malaysia – Pap smear Test Market (Million US$), 2011 – 2017
Figure 7‑10: Malaysia – Forecast for Pap smear Test Market (Million US$), 2018 – 2024
Figure 7‑11: Malaysia – HPV DNA Test Market (Million US$), 2011 – 2017
Figure 7‑12: Malaysia – Forecast for HPV DNA Test Market (Million US$), 2018– 2024
Figure 8‑1: India – Cervical Cancer Test Population (Thousand), 2011 – 2017
Figure 8‑2: India – Forecast for Cervical Cancer Test Population (Thousand), 2018 – 2024
Figure 8‑3: India – Cervical Cancer Pap Smear Test Population (Thousand), 2011 – 2017
Figure 8‑4: India – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 – 2024
Figure 8‑5: India – Cervical Cancer HPV DNA Test Population (Thousand), 2011 – 2017
Figure 8‑6: India – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 – 2024
Figure 8‑7: India – Cervical Cancer VIA Test Population (Thousand), 2011 – 2017
Figure 8‑8: India – Forecast for Cervical Cancer VIA Test Population (Thousand), 2018 – 2024
Figure 8‑9: India – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 8‑10: India – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 8‑11: India – Pap smear Test Market (Million US$), 2011 – 2017
Figure 8‑12: India – Forecast for Pap smear Test Market (Million US$), 2018 – 2024
Figure 8‑13: India – HPV DNA Test Market (Million US$), 2011 – 2017
Figure 8‑14: India – Forecast for HPV DNA Test Market (Million US$), 2018 – 2024
Figure 8‑15: India – VIA Test Market (Million US$), 2011 – 2017
Figure 8‑16: India – Forecast for VIA Test Market (Million US$), 2018 – 2024
Figure 9‑1: China – Cervical Cancer Test Population (Thousand), 2011 – 2017
Figure 9‑2: China – Forecast for Cervical Cancer Test Population (Thousand), 2018 – 2024
Figure 9‑3: China – Cervical Cancer Pap Smear Test Population (Thousand), 2011 – 2017
Figure 9‑4: China – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 – 2024
Figure 9‑5: China – Cervical Cancer HPV DNA Test Population (Thousand), 2011 – 2017
Figure 9‑6: China – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 – 2024
Figure 9‑7: China – Cervical Cancer VIA Test Population (Thousand), 2011 – 2017
Figure 9‑8: China – Forecast for Cervical Cancer VIA Test Population (Thousand), 2018 – 2024
Figure 9‑9: China – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 9‑10: China – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 9‑11: China – Pap smear Test Market (Million US$), 2011 – 2017
Figure 9‑12: China – Forecast for Pap Smear Test Market (Million US$), 2018 – 2024
Figure 9‑13: China – HPV DNA Test Market (Million US$), 2011 – 2017
Figure 9‑14: China – Forecast for HPV DNA Test Market (Million US$), 2018 – 2024
Figure 9‑15: China – VIA Test Market (Million US$), 2011 – 2017
Figure 9‑16: China – Forecast for VIA Test Market (Million US$), 2018 – 2024
Figure 10‑1: Thailand – Cervical Cancer Test Population (Thousand), 2011 – 2017
Figure 10‑2: Thailand – Cervical Cancer Test Population (Thousand), 2018 – 2024
Figure 10‑3: Thailand – Cervical Cancer Pap Smear Test Population (Thousand), 2011 – 2017
Figure 10‑4: Thailand – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 – 2024
Figure 10‑5: Thailand – Cervical Cancer VIA Test Population (Thousand), 2011 – 2017
Figure 10‑6: Thailand – Forecast for Cervical Cancer VIA Test Population (Thousand), 2018 – 2024
Figure 10‑7: Thailand – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 10‑8: Thailand – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 10‑9: Thailand – Pap smear Test Market (Million US$), 2011 – 2017
Figure 10‑10: Thailand – Forecast for Pap Smear Test Market (Million US$), 2018 – 2024
Figure 10‑11: Thailand – VIA Test Market (Million US$), 2011 – 2017
Figure 10‑12: Thailand – Forecast for VIA Test Market (Million US$), 2018 – 2024
Figure 11‑1: Indonesia – Cervical Cancer Test Population (Thousand), 2011 – 2017
Figure 11‑2: Indonesia – Forecast for Cervical Cancer Test Population (Thousand), 2018 – 2024
Figure 11‑3: Indonesia – Cervical Cancer Pap Smear Test Population (Thousand), 2011 – 2017
Figure 11‑4: Indonesia – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 – 2024
Figure 11‑5: Indonesia – Cervical Cancer HPV DNA Test Population (Thousand), 2011 – 2017
Figure 11‑6: Indonesia – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 – 2024
Figure 11‑7: Indonesia – Cervical Cancer VIA Test Population (Thousand), 2011 – 2017
Figure 11‑8: Indonesia – Forecast for Cervical Cancer VIA Test Population (Thousand), 2018 – 2024
Figure 11‑9: Indonesia – Cervical Cancer Both (Pap smear & VIA) Test Population (Thousand), 2011 – 2017
Figure 11‑10: Indonesia – Forecast for Cervical Cancer Both (Pap smear & VIA) Test Population (Thousand), 2018 – 2024
Figure 11‑11: Indonesia – Cervical Cancer Test Market (Million US$), 2011 – 2017
Figure 11‑12: Indonesia – Forecast for Cervical Cancer Test Market (Million US$), 2018 – 2024
Figure 11‑13: Indonesia – Pap Smear Test Market (Million US$), 2011 – 2017
Figure 11‑14: Indonesia – Forecast for Pap Smear Test Market (Million US$), 2018 – 2024
Figure 11‑15: Indonesia – HPV DNA Test Market (Million US$), 2011 – 2017
Figure 11‑16: Indonesia – Forecast for HPV DNA Test Market (Million US$), 2018 – 2024
Figure 11‑17: Indonesia – VIA Test Market (Million US$), 2011 – 2017
Figure 11‑18: Indonesia – Forecast for VIA Test Market (Million US$), 2018 – 2024
Figure 11‑19: Indonesia – Both (Pap smear & VIA) Test Market (Million US$), 2011 – 2017
Figure 11‑20: Indonesia – Forecast for Both (Pap smear & VIA) Test Market (Million US$), 2018 – 2024

  • Global Prostate Cancer Diagnostics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116
    According to our LPI (LP Information) latest study, the global Prostate Cancer Diagnostics market size was valued at US$ 13140 million in 2023. With growing demand in downstream market, the Prostate Cancer Diagnostics is forecast to a readjusted size of US$ 22650 million by 2030 with a CAGR of 8.1% during review period. The research report highlights the growth potential of the global Prostate Cancer Diagnostics market. Prostate Cancer Diagnostics are expected to show stable growth in th......
  • Global Checkpoint Inhibitors for Treating Cancer Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 83
    According to our LPI (LP Information) latest study, the global Checkpoint Inhibitors for Treating Cancer market size was valued at US$ 12220 million in 2023. With growing demand in downstream market, the Checkpoint Inhibitors for Treating Cancer is forecast to a readjusted size of US$ 63530 million by 2030 with a CAGR of 26.6% during review period. The research report highlights the growth potential of the global Checkpoint Inhibitors for Treating Cancer market. Checkpoint Inhibitors for......
  • Global PSA Test Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 111
    According to our LPI (LP Information) latest study, the global PSA Test market size was valued at US$ 499.9 million in 2023. With growing demand in downstream market, the PSA Test is forecast to a readjusted size of US$ 861.8 million by 2030 with a CAGR of 8.1% during review period. The research report highlights the growth potential of the global PSA Test market. PSA Test are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
  • Global HPV Testing Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 87
    According to our LPI (LP Information) latest study, the global HPV Testing market size was valued at US$ 784.6 million in 2023. With growing demand in downstream market, the HPV Testing is forecast to a readjusted size of US$ 1398.7 million by 2030 with a CAGR of 8.6% during review period. The research report highlights the growth potential of the global HPV Testing market. HPV Testing are expected to show stable growth in the future market. However, product differentiation, reducing cos......
  • Global Prostate Cancer Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 102
    According to our (Global Info Research) latest study, the global Prostate Cancer Diagnostics market size was valued at USD 13820 million in 2023 and is forecast to a readjusted size of USD 22870 million by 2030 with a CAGR of 7.5% during review period. The prostate is a walnut-sized gland located behind the base of a man's penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be ......
  • Global Pap Tests and HPV Tests Market Research Report 2023, Forecast to 2028
    Published: 28-Dec-2023        Price: US 2680 Onwards        Pages: 130
    The Pap test (or Pap smear) looks for precancers, cell changes on the cervix that might become cervical cancer if they are not treated appropriately. The HPV test looks for the virus (human papillomavirus) that can cause these cell changes. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can......
  • Global Pap Tests and HPV Tests Professional Survey Report 2023, Forecast to 2028
    Published: 28-Dec-2023        Price: US 3280 Onwards        Pages: 106
    The Pap test (or Pap smear) looks for precancers, cell changes on the cervix that might become cervical cancer if they are not treated appropriately. The HPV test looks for the virus (human papillomavirus) that can cause these cell changes. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can......
  • Global Checkpoint Inhibitors For Treating Cancer Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 102
    Market Overview of Global Checkpoint Inhibitors For Treating Cancer market: According to our latest research, the global Checkpoint Inhibitors For Treating Cancer market looks promising in the next 5 years. As of 2022, the global Checkpoint Inhibitors For Treating Cancer market was estimated at USD 18595.4 million, and it's anticipated to reach USD 42557.61 million in 2028, with a CAGR of 14.8% during the forecast years. Checkpoint inhibitor is a type of drug used in immunoth......
  • Global Solid Tumor Testing Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 100
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs